Education and demonstration – Means for demonstrating apparatus – product – or surface... – Demonstration or display means combined with storage or...
Patent
1997-05-01
1999-11-30
Page, Thurman K.
Education and demonstration
Means for demonstrating apparatus, product, or surface...
Demonstration or display means combined with storage or...
424422, 424450, 514943, A61K 4744, A61K 9127, A61M 500
Patent
active
059932210
ABSTRACT:
A novel formulation which contains about 2-60% by calories of a C.sub.20 or longer .omega.3 fatty acid moiety and about 2-60% by calories of an arachidonic acid moiety has been developed. This formulation is particularly useful for restoring arachidonic acid levels, increasing immunity or minimizing risk of infection in critically ill patients, and treating functional essential fatty acid deficiency in patients suffering from end stage liver disease. A structured lipid which has a C.sub.20 or longer .omega.3 fatty acid moiety and an arachidonic acid moiety has also been developed.
REFERENCES:
patent: 4820731 (1989-04-01), Mascioli
patent: 5231085 (1993-07-01), Alexander
patent: 5308832 (1994-05-01), Garleb
patent: 5340594 (1994-08-01), Barclay
patent: 5514656 (1996-05-01), Cope
patent: 5574065 (1996-11-01), Trimbo
Cabre, E. et al., "Polyunsaturated Fatty Acid Deficiency in Liver Cirrhosis: Its Relation to Associated Protein-Energy Malnutrition (Preliminary Report)", The American Journal of Gastroenterology, vol. 83 (7), pp. 712-717 (1988).
Cabre, E. et al., "Polyunsaturated Fatty Acid Deficiency in Liver Diseases: Pathophysiological and Clinical Significance", Nutrition, vol. 12 (7/8), pp. 542-548 (1996).
Mendenhall, C. et al., "Protein-Calorie Malnutrition Associated with Alcoholic Hepatitis", The American Journal of Medicine, vol. 76, pp. 211-222 (1984).
Mendenhall, C. et al., "VA Cooperative Study on Alcoholic Hepatitis II: Prognostic Significance of Protein-Calorie Malnutrition", The American Journal of Clinical Nutrition, vol. 43, pp. 213-218 (1986).
McCullough, A. et al., "Disordered Energy and Protein Metabolism in Liver Disease", Seminars in Liver Disease, vol. 11 (4), pp. 265-277 (1991).
Morgan, A. et al., "Nutrition in Cryptogenic Cirrhosis and Chronic Aggressive Hepatitis", GUT, vol. 17, pp. 113-118 (1976).
O'Keefe, S. et al., "Malnutrition and Immuno-Imcompetence in Patients with Liver Disease", Lancet, vol. 2, pp. 615-617 (1980).
Palombo, J. et al., "Effectiveness of Orthotopic Liver Transplantation on the Restoration of Cholesterol Metabolism in Patients with End-Stage Liver Disease", Gastroenterology, vol. 93, pp. 1170-1177 (1987).
Berman Alysia
Beth Israel Deaconess Medical Center Inc.
Page Thurman K.
LandOfFree
Dietary formulation comprising arachidonic acid and methods of u does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dietary formulation comprising arachidonic acid and methods of u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dietary formulation comprising arachidonic acid and methods of u will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1664659